Edwin Coe advises Onzima Ventures Plc on Reverse Takeover and Re-admission to AIM
Edwin Coe advised Onzima Ventures Plc on the acquisition of the remaining 51% of the issued shares of N4 Pharma Limited which it did not already own. The transaction constituted a Reverse Takeover…
Read the full articleYou might also wanna read
Edwin Coe further increases its strength in Private Capital and Litigation
Edwin Coe·1y ago
Edwin Coe enhances Private Capital and Corporate offering with new Financial Regulation and Banking & Finance teams
Edwin Coe·1y ago
Edwin Coe advises healthcare specialist on acquisition of Five Mobility Group
Edwin Coe·1y ago
Edwin Coe advises Nagarro on the strategic acquisition of FWD View Limited
Edwin Coe·1y ago
Chambers UK 2025 Guide recommends Edwin Coe’s leading lawyers and practices
Edwin Coe·1y ago
Edwin Coe widely ranked in Legal 500 UK 2025
Edwin Coe·1y ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.